Neoadjuvant therapy for gastric cancer: current evidence and future directions

Journal of Gastrointestinal Oncology

Andrew D. Newton²  Arturo Loaiza-Bonilla¹  Robert E. Roses²  Giorgos C. Karakousis²  Jashodeep Datta² 

[1] Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USADivision of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USADivision of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA;Department of Surgery,Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USADepartment of Surgery,Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USADepartment of Surgery,Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA

关键词: Gastric cancer (GC);    neoadjuvant therapy;    multimodality therapy;    surgery;    chemotherapy;    radiotherapy;    chemoradiotherapy (CRT);   

DOI  :  10.3978/j.issn.2078-6891.2015.047

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown